Scientific ReportsGenetic & Genomic MedicinePeer-reviewed journal article
Variant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population
Claribel Tian Yu Foo, Yi Hui To, Astrid K IrwantoiD, Alvin Yu Jin NgiD, Benedict YaniD, Sophia Tsong Huey ChewiD, Jianjun LiuiD, Lian Kah TiiD
Abstract
BackgroundThe RYR1 gene codes for a ryanodine receptor which is a calcium release channel in the skeletal muscle sarcoplasmic reticulum. It is associated with Malignant Hyperthermia (MH) and several congenital myopathies including Central Core Disease (CCD), Multiminicore Disease (MMD) and Congenital Fibre-Type Disproportion (CFTD). There is currently little information on the epidemiology of RYR1 variants in Asians. Our study aims to describe the RYR1 variant landscape in a Singapore cohort unselected for RYR1-associated conditions. MethodsData was retrieved from the SG10K pilot project, where whole genome sequencing was performed on volunteers unselected and undetermined for RYR1-associated conditions. Variants were classified based on pathogenicity using databases ClinVar and InterVar. Allele frequencies of pathogenic variants were compared between Chinese, Indians and Malays. Using databases ExAC, GnomAD and GenomeAsia 100k study, we further compared local allele frequencies to those in Europe, America and Asia. ResultsMajority of the RYR1 variants were missense mutations. We identified four pathogenic and four likely pathogenic RYR1 variants. All were related to the aforementioned RYR1-associated conditions. There were 6 carriers of RYR1 pathogenic variants amongst 4810 individuals, corresponding to an allele frequency of 0.06%. The prevalence of pathogenic variants was the highest amongst Indians (4 in 1127 individuals). Majority of pathogenic and likely pathogenic mutations were missense and located in mutational hotspots. These variants also occurred at higher frequencies in Asians than globally. ConclusionThis study describes the variant landscape of the RYR1 gene in Singapore. This knowledge will facilitate local efforts in developing precision medicine.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 7
- FWCI
- 0.75
- Field percentile
- top 33%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Updated Variant Curation Expert Panel Criteria and Pathogenicity Classifications for 251 Variants for RYR1-related Malignant Hyperthermia Susceptibility
Jennifer J. Johnston, Robert T. Dirksen, … Leslie G. Biesecker·Human Molecular GeneticsPeer-reviewed·Jul 15, 2022
- Variant Curation Expert Panel Recommendations for RYR1 Pathogenicity Assertions in Malignant Hyperthermia Susceptibility
Jennifer J. Johnston, Robert T. Dirksen, … Leslie G. Biesecker·Genetics in MedicinePeer-reviewed·Mar 25, 2021
- Functional benefit of CRISPR/Cas9-induced allele deletion for RYR1 dominant mutation
Mathilde Beaufils, Margaux Melka, … Isabelle Marty·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jun 17, 2024
- Complementary roles of structure and variant effect predictors in RyR1 clinical interpretation
Rolando Hernández Trapero, Mihaly Badonyi, … Joseph A. Marsh·Human MutationPeer-reviewed·Jan 1, 2025
- Ryanodine receptor 1 ( RYR1 ) patient-derived muscle cells recapitulate disease phenotypes in 2D and 3D culture models
Joshua S. Clayton, Jordan Crane, … Rhonda L. Taylor·bioRxiv·Jun 20, 2026
- Plasma Micro-RNA Signatures of Type 1 Ryanodine Receptor Related Myopathies
Pooja Varma, Mayra Saintilus, … Tokunbor A. Lawal·bioRxiv·May 16, 2026